Immediate Impact

1 by Nobel laureates 2 from Science/Nature 55 hit
Sub-graph 1 of 23

Citing Papers

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
2024 Hit
Thyroid Cancer
2024 Hit
2 intermediate papers

Works of Reiko Watanabe being referenced

Efficacy of alogliptin, a dipeptidyl peptidase‐4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) – receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes
2013
Long Term Parathyroid Function Following Total Parathyroidectomy with Autotransplantation in Adult Patients with MEN2A
2009

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Reiko Watanabe 750 447 406 371 321 104 2.4k
Joseph J. Bunim 354 0.5× 1.6k 3.7× 263 0.6× 282 0.8× 394 1.2× 70 4.4k
Frans J. Hoek 375 0.5× 291 0.7× 813 2.0× 77 0.2× 392 1.2× 68 3.5k
Yolanda Jiménez 407 0.5× 735 1.6× 957 2.4× 116 0.3× 596 1.9× 117 4.7k
Sayaka Katagiri 283 0.4× 332 0.7× 735 1.8× 236 0.6× 197 0.6× 107 2.0k
Leonard C. Altman 297 0.4× 607 1.4× 471 1.2× 106 0.3× 145 0.5× 58 2.4k
Anthony D. Ormerod 211 0.3× 537 1.2× 224 0.6× 93 0.3× 721 2.2× 99 4.3k
François Chapuis 512 0.7× 224 0.5× 75 0.2× 181 0.5× 535 1.7× 83 3.4k
Pekka Vilja 196 0.3× 592 1.3× 543 1.3× 130 0.4× 126 0.4× 67 2.3k
Saaeha Rauz 976 1.3× 567 1.3× 108 0.3× 792 2.1× 208 0.6× 147 4.0k
Necil Kütükçüler 218 0.3× 221 0.5× 464 1.1× 48 0.1× 415 1.3× 165 2.8k

All Works

Loading papers...

Rankless by CCL
2026